Ocular diseases cause vision deficiency and blindness in a substantial number of people in the world every day. Therefore, a controlled and sustained system of drug delivery to a specific spot within the eye is of interest for the ophthalmology community. The unique and complicated anatomy, physiology, and biochemistry of the eye make this organ highly resistant to drug delivery systems. The major challenge is to improve the efficiency of each treatment method along with avoiding the invasive techniques which damage the eye’s protective barrier tissues. In this work we make a computer model for the drug delivery to the anterior sections of the eye and provide a summary of transport characteristics of the eye, pharmacokinetics and efficacy of the utilized drugs. A two dimensional finite element model is utilized to solve the conservation of mass and momentum equations within different eye sub-domains such as cornea, anterior chamber, iris and sclera. The commercial software Comsol Multiphysics was utilized to obtain the profile of concentration in the eye and the grid independency of the numerical results has been checked. The results are being shown in terms of transient drug concentration profile in the eye subdomains. The influence of the modeling parameters on the efficiency of the drug delivery system is studied. The effect of physical variables such as drug molecular size and its bioavailability are investigated. The results are compared with the available literature data which are based on the drug diffusion within the domain.
Model of Drug Delivery to the Eye
- Views Icon Views
- Share Icon Share
- Search Site
Shafahi, M, & Piroozan, P. "Model of Drug Delivery to the Eye." Proceedings of the ASME 2014 International Mechanical Engineering Congress and Exposition. Volume 3: Biomedical and Biotechnology Engineering. Montreal, Quebec, Canada. November 14–20, 2014. V003T03A077. ASME. https://doi.org/10.1115/IMECE2014-39438
Download citation file: